The Hippo pathway mediates inhibition of vascular smooth muscle cell proliferation by cAMP

Journal of Molecular and Cellular Cardiology

Volumn 90, Issue , 2016, Pages 1-10

  Kimura, Tomomi E ^a   Duggirala, Aparna ^a   Smith, Madeleine C ^a   White, Stephen ^a   Sala Newby, Graciela B ^a   Newby, Andrew C ^a   Bond, Mark ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

3' 5' Cyclic adenosine monophosphate; CAMP; TAZ; TEAD; VSMC; YAP

Indexed keywords

ADENOSINE; BUCLADESINE; CICAPROST; CYCLIC AMP; EXOENZYME C3; FORSKOLIN; LATRUNCULIN B; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TAZ; TRANSCRIPTION FACTOR TEAD; TRANSCRIPTION FACTOR YAP; UNCLASSIFIED DRUG; VERTEPORFIN; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; AMIDE; APOPTOSIS REGULATORY PROTEIN; CONNECTIVE TISSUE GROWTH FACTOR; CTGF PROTEIN, RAT; CYR61 PROTEIN, RAT; CYSTEINE RICH PROTEIN 61; FUSED HETEROCYCLIC RINGS; MYC PROTEIN; PROSTACYCLIN; PYRIDINE DERIVATIVE; SIGNAL PEPTIDE; TGFB2 PROTEIN, RAT; THIAZOLIDINE DERIVATIVE; TRANSFORMING GROWTH FACTOR BETA2; WWTR1 PROTEIN, RAT; YAP PROTEIN, RAT;

ACTIN POLYMERIZATION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CCN1 GENE; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; CTGF GENE; ENZYME REPRESSION; GENE; GENE FUNCTION; GENETIC TRANSFECTION; HIPPO SIGNALING PATHWAY; MALE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TGFB2 GENE; VASCULAR SMOOTH MUSCLE CELL; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PRIMARY CELL CULTURE; RAT; SMOOTH MUSCLE; SMOOTH MUSCLE CELL; SPRAGUE DAWLEY RAT;

AMIDES; ANIMALS; APOPTOSIS REGULATORY PROTEINS; BRIDGED BICYCLO COMPOUNDS, HETEROCYCLIC; BUCLADESINE; CELL PROLIFERATION; COLFORSIN; CONNECTIVE TISSUE GROWTH FACTOR; CYCLIC AMP; CYSTEINE-RICH PROTEIN 61; EPOPROSTENOL; GENE EXPRESSION REGULATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MUSCLE, SMOOTH; MYOCYTES, SMOOTH MUSCLE; PRIMARY CELL CULTURE; PROTO-ONCOGENE PROTEINS C-MYC; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RHO-ASSOCIATED KINASES; SIGNAL TRANSDUCTION; THIAZOLIDINES; TRANSFORMING GROWTH FACTOR BETA2;

EID: 84949200386     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2015.11.024     Document Type: Article

References (55)

1. Southgate K.M., Newby A.C. Serum-induced proliferation of rabbit aortic smooth muscle cells from the contractile state is inhibited by 8-Br-cAMP but not 8-Br-cGMP. Atherosclerosis 1990, 82:113-123.
2. Wu Y.J., Bond M., Sala-Newby G.B., Newby A.C. Altered S-phase kinase-associated protein-2 levels are a major mediator of cyclic nucleotide-induced inhibition of vascular smooth muscle cell proliferation. Circ. Res. 2006, 98:1141-1150.
3. Palmer D., Maurice D.H. cAMP-mediated inhibition of vascular smooth muscle cell migration: role of cAMP-phosphodiesterases. Mol. Biol. Cell 1997, 8:764.
4. Howe A. Regulation of actin-based cell migration by cAMP/PKA. Biochim. Biophys. Acta Mol. Cell Res. 1692, 2004:159-174.
5. Indolfi C., Di Lorenzo E., Rapacciuolo A., Stingone A.M., Stabile E., Leccia A., et al. 8-Chloro-cAMP inhibits smooth muscle cell proliferation in vitro and neointima formation induced by balloon injury in vivo. J. Am. Coll. Cardiol. 2000, 36:288-293.
6. Savai R., Pullamsetti S.S., Banat G.A., Weissmann N., Ghofrani H.A., Grimminger F., et al. Targeting cancer with phosphodiesterase inhibitors. Expert Opin. Investig. Drugs 2010, 19:117-131.
7. Netherton S.J., Jimmo S.L., Palmer D., Tilley D.G., Dunkerley H.A., Raymond D.R., et al. Altered phosphodiesterase 3-mediated cAMP hydrolysis contributes to a hypermotile phenotype in obese JCR: LA-cp rat aortic vascular smooth muscle cells - implications for diabetes-associated cardiovascular disease. Diabetes 2002, 51:1194-1200.
8. Jeremy J.Y., Dashwood M.R., Timm M., Izzat M.B., Mehta D., Bryan A.J., et al. Nitric oxide synthase and adenylyl and guanylyl cyclase activity in porcine interposition vein grafts. Ann. Thorac. Surg. 1997, 63:470-476.
9. Jeremy J.Y., Birkett S.D., Bryan A.J., Angelini G.D. The influence of surgical preparation on cyclic nucleotide synthesis in an organ culture of human saphenous vein. Eur. J. Vasc. Endovasc. Surg. 1997, 13:72-78.
10. Jeremy J.Y., Dashwood M.R., Mehta D., Izzat M.B., Shukla N., Angelini G.D. Nitric oxide, prostacyclin and cyclic nucleotide formation in externally stented porcine vein grafts. Atherosclerosis 1998, 141:297-305.
11. Yokoyama U., Minamisawa S., Quan H., Akaike T., Jin M.H., Otsu K., et al. Epac1 is upregulated during neointima formation and promotes vascular smooth muscle cell migration. Am. J. Physiol. Heart Circ. Physiol. 2008, 295:H1547-H1555.
12. Schauer I.E., Knaub L.A., Lloyd M., Watson P.A., Gliwa C., Lewis K.E., et al. CREB downregulation in vascular disease a common response to cardiovascular risk. Arterioscler. Thromb. Vasc. Biol. 2010, 30:733-741.
13. Murray F., Patel H.H., Suda R.Y.S., Zhang S., Thistlethwaite P.A., Yuan J.X.J., et al. Expression and activity of cAMP phosphodiesterase isoforms in pulmonary artery smooth muscle cells from patients with pulmonary hypertension: role for PDE1. Am. J. Physiol. Lung Cell. Mol. Physiol. 2007, 292:L294-L303.
14. Jing Q., Xin S.M., Cheng Z.J., Zhang W.B., Zhang R., Qin Y.W., et al. Activation of p38 mitogen-activated protein kinase by oxidized LDL in vascular smooth muscle cells - mediation via pertussis toxin-sensitive G proteins and association with oxidized LDL-induced cytotoxicity. Circ. Res. 1999, 84:831-839.
15. Mayr B., Montminy M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat. Rev. Mol. Cell Biol. 2001, 2:599-609.
16. Hewer R.C., Sala-Newby G.B., Wu Y.J., Newby A.C., Bond M. PKA and Epac synergistically inhibit smooth muscle cell proliferation. J. Mol. Cell. Cardiol. 2011, 50:87-98.
17. Klemm D.J., Watson P.A., Frid M.G., Dempsey E.C., Schaack J., Colton L.A., et al. cAMP response element-binding protein content is a molecular determinant of smooth muscle cell proliferation and migration. J. Biol. Chem. 2001, 276:46132-46141.
18. Tokunou T., Ichiki T., Takeda K., Funakoshi Y., Iino N., Takeshita A. cAMP response element-binding protein mediates thrombin-induced proliferation of vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 2001, 21:1764-1769.
19. Bond M., Wu Y.J., Sala-Newby G.B., Newby A.C. Rho GTPase, Rac(1), regulates Skp(2) levels, vascular smooth muscle cell proliferation, and intima formation in vitro and in vivo. Cardiovasc. Res. 2008, 80:290-298.
20. Kimura T.E., Duggirala A., Hindmarch C.C.T., Hewer R.C., Cui M.Z., Newby A.C., et al. Protein kinase A and EPAC synergistically inhibit Egr1 expression and proliferation in vascular smooth muscle cells. JMCC 2014, 72:9-19.
21. Pelletier S., Julien C., Popoff M., Lamarche-Vane N., Meloche S. Cyclic AMP induces morphological changes of vascular smooth muscle cells by inhibiting a Rac-dependent signaling pathway. J. Cell. Physiol. 2005, 204:412-422.
22. Huang J.B., Wu S., Barrera J., Matthews K., Pan D.J. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila homolog of YAP. Cell 2005, 122:421-434.
23. Camargo F.D., Gokhale S., Johnnidis J.B., Fu D., Bell G.W., Jaenisch R., et al. YAP1 increases organ size and expands undifferentiated progenitor cells. Curr. Biol. 2007, 17:2054-2060.
24. Dong J., Feldmann G., Huang J., Wu S., Zhang N., Comerford S.A., et al. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 2007, 130:1120-1133.
25. Yang R., Wu Y.N., Wang M., Sun Z.F., Zou J.H., Zhang Y.D., et al. HDAC9 promotes glioblastoma growth via TAZ-mediated EGFR pathway activation. Oncotarget 2015, 6:7644-7656.
26. Wang M., Liu Y., Zou J., Yang R., Xuan F., Wang Y., et al. Transcriptional co-activator TAZ sustains proliferation and tumorigenicity of neuroblastoma by targeting CTGF and PDGF-beta. Oncotarget 2015, 6:9517-9530.
27. Xiao H., Jiang N., Zhou B.Y., Liu Q., Du C.Y. TAZ regulates cell proliferation and epithelial-mesenchymal transition of human hepatocellular carcinoma. Cancer Sci. 2015, 106:151-159.
28. Zhao B., Ye X., Yu J., Li L., Li W., Li S., et al. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev. 2008, 22:1962-1971.
29. Sawada A., Kiyonari H., Ukita K., Nishioka N., Imuta Y., Sasaki H. Redundant roles of Tead1 and Tead2 in notochord development and the regulation of cell proliferation and survival. Mol. Cell. Biol. 2008, 28:3177-3189.
30. Plouffe S.W., Hong A.W., Guan K.L. Disease implications of the Hippo/YAP pathway. Trends Mol. Med. 2015, 21:212-222.
31. Sansores-Garcia L., Bossuyt W., Wada K.-I., Yonemura S., Tao C., Sasaki H., et al. Modulating F-actin organization induces organ growth by affecting the Hippo pathway. Embo J. 2011, 30:2325-2335.
32. Dupont S., Morsut L., Aragona M., Enzo E., Giulitti S., Cordenonsi M., et al. Role of YAP/TAZ in mechanotransduction. Nature 2011, 474:179-U212.
33. Bond M., Sala-Newby G., Wu Y., Newby A. Biphasic effect of p21Cip1 on vascular smooth muscle cell proliferation: role of PI3-kinase signalling and Skp2-mediated degradation. Cardiovasc. Res. 2006, 69:198-206.
34. Zhao B., Wei X., Li W., Udan R.S., Yang Q., Kim J., et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 2007, 21:2747-2761.
35. Duggirala A., Newby A.C., Bond M. cAMP inhibits expression of the proangiogenic factor CCN1/CYR61 in vascular smooth muscle cells by inhibiting RhoA and actin-dependent regulation of MRTF. J. Mol. Cell. Cardiol. 2014, 79:157-168.
36. Lai D., Ho K.C., Hao Y., Yang X. Taxol resistance in breast cancer cells is mediated by the Hippo pathway component TAZ and its downstream transcriptional targets Cyr61 and CTGF. Cancer Res. 2011, 71:2728-2738.
37. Burdyga A., Conant A., Haynes L., Zhang J., Jalink K., Sutton R., et al. cAMP inhibits migration, ruffling and paxillin accumulation in focal adhesions of pancreatic ductal adenocarcinoma cells: effects of PKA and EPAC. Biochim. Biophys. Acta Mol. Cell Res. 1833, 2013:2664-2672.
38. Liu L., Xu X., Li J., Li X., Sheng W. Lentiviral-mediated shRNA silencing of PDE4D gene inhibits platelet-derived growth factor-induced proliferation and migration of rat aortic smooth muscle cells. Stroke Res. Treat. 2011, 2011:534257.
39. Koyama N., Morisaki N., Saito Y., Yoshida S. Regulatory effects of platelet-derived growth factor-AA homodimer on migration of vascular smooth muscle cells. J. Biol. Chem. 1992, 267:22806-22812.
40. Zhao B., Li L., Tumaneng K., Wang C.-Y., Guan K.-L. A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF beta-TRCP. Genes Dev. 2010, 24:72-85.
41. Wu Y., Bond M., Sala-Newby G., Newby A. Altered S-phase kinase-associated protein-2 levels are a major mediator of cyclic nucleotide-induced inhibition of vascular smooth muscle cell proliferation. Circ. Res. 2006, 98:1141-1150.
42. Liu-Chittenden Y., Huang B., Shim J.S., Chen Q., Lee S.-J., Anders R.A., et al. Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP. Genes Dev. 2012, 26:1300-1305.
43. Hernandez-Negrete I., Sala-Newby G.B., Perl A., Kunkel G.R., Newby A.C., Bond M. Adhesion-dependent Skp2 transcription requires selenocysteine tRNA gene transcription-activating factor (STAF). Biochem. J. 2011, 436:133-143.
44. Hewer R.C., Sala-Newby G.B., Wu Y.-J., Newby A.C., Bond M. PKA and Epac synergistically inhibit smooth muscle cell proliferation. J. Mol. Cell. Cardiol. 2011, 50:87-98.
45. Wang X., Hu G., Gao X., Wang Y., Zhang W., Harmon E.Y., et al. The induction of yes-associated protein expression after arterial injury is crucial for smooth muscle phenotypic modulation and neointima formation. Arterioscler. Thromb. Vasc. Biol. 2012, 32:2662.
46. Wang R., Xu Y.-J., Liu X.-S., Zeng D.-X., Xiang M. CCN2 promotes cigarette smoke-induced proliferation of rat pulmonary artery smooth muscle cells through upregulating cyclin D1 expression. J. Cell. Biochem. 2012, 113:349-359.
47. Shi Y., Fard A., Galeo A., Hutchinson H.G., Vermani P., Dodge G.R., et al. Transcatheter delivery of c-myc antisense oligomers reduces neointimal formation in A porcine model of coronary-artery balloon injury. Circulation 1994, 90:944-951.
48. Ota M., Sasaki H. Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling. Development 2008, 135:4059-4069.
49. Lamar J.M., Stern P., Liu H., Schindler J.W., Jiang Z.G., Hynes R.O. The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:E2441-E2450.
50. Jeong G.O., Shin S.H., Seo E.J., Kwon Y.W., Heo S.C., Kim K.H., et al. TAZ mediates lysophosphatidic acid-induced migration and proliferation of epithelial ovarian cancer cells. Cell. Physiol. Biochem. 2013, 32:253-263.
51. Aragona M., Panciera T., Manfrin A., Giulitti S., Michielin F., Elvassore N., et al. A mechanical checkpoint controls multicellular growth through YAP/TAZ regulation by actin-processing factors. Cell 2013, 154:1047-1059.
52. Wang Y., Hu G., Liu F., Wang X., Wu M., Schwarz J.J., et al. Deletion of yes-associated protein (YAP) specifically in cardiac and vascular smooth muscle cells reveals a crucial role for YAP in mouse cardiovascular development. Circ. Res. 2014, 114:957-965.
53. Xie C.Q., Guo Y.H., Zhu T.Q., Zhang J.F., Ma P.X., Chen Y.E. Yap1 protein regulates vascular smooth muscle cell phenotypic switch by interaction with myocardin. J. Biol. Chem. 2012, 287:14598-14605.
54. LAllemain G., Lavoie J., Rivard N., Baldin V., Pouyssegur J. Cyclin D1 expression is a major target of the cAMP-induced inhibition of cell cycle entry in fibroblasts. Oncogene 1997, 14:1981-1990.
55. Haque I., De A., Majumder M., Mehta S., McGregor D., Banerjee S.K., et al. The matricellular protein CCN1/Cyr61 is a critical regulator of sonic hedgehog in pancreatic carcinogenesis. J. Biol. Chem. 2012, 287:38569-38579.